Novartis Seeks EU Fast Track For Iptacopan In Two Indications

 
• By Neena Brizmohun
  
Calendar
An accelerated assessment can cut months off the standard review time • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards